{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:51:39Z","timestamp":1789408299133,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015644","name":"Pancreas Research Foundation of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015644","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.canlet.2020.07.034","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T21:56:40Z","timestamp":1596146200000},"page":"174-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model"],"prefix":"10.1016","volume":"492","author":[{"given":"Jun","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Inubushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-7268","authenticated-orcid":false,"given":"Norihiko","family":"Sugisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8574-5305","authenticated-orcid":false,"given":"Yoshihiko","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusei","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sant P.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-583X","authenticated-orcid":false,"given":"Shree Ram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.07.034_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/MPA.0000000000000588","article-title":"Recent trends in survival of patients with pancreatic cancer in Germany and the United States","volume":"45","author":"Sirri","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.canlet.2020.07.034_bib2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2020.07.034_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2020.07.034_bib5","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1073\/pnas.73.5.1523","article-title":"High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine","volume":"73","author":"Hoffman","year":"1976","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.canlet.2020.07.034_bib6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1073\/pnas.76.3.1313","article-title":"Reversion to methionine independence in simian virus 40-transformed human and malignant rat fibroblasts is associated with altered ploidy and altered properties of transformation","volume":"76","author":"Hoffman","year":"1979","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.canlet.2020.07.034_bib7","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.77.12.7306","article-title":"Reversible growth arrest in simian virus 40-transformed human fibroblasts","volume":"77","author":"Hoffman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.canlet.2020.07.034_bib8","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1073\/pnas.79.14.4248","article-title":"Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells","volume":"79","author":"Coalson","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.07.034_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF02619617","article-title":"Elevated overall rates of transmethylation in cell lines from diverse human tumors","volume":"20","author":"Stern","year":"1984","journal-title":"In Vitro"},{"key":"10.1016\/j.canlet.2020.07.034_bib10","first-page":"5676","article-title":"Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo","volume":"53","author":"Guo","year":"1993","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib38","first-page":"717","article-title":"Human tumors are methionine dependent in vivo","volume":"15","author":"Hoshiya","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jnci\/76.4.629","article-title":"Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect","volume":"76","author":"Stern","year":"1986","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2020.07.034_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bjc.1980.210","article-title":"Effect of methionine deprivation on methylation and synthesis of macromolecules","volume":"42","author":"Tisdale","year":"1980","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2020.07.034_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040568","article-title":"Methionine dependence of cancer","volume":"10","author":"Kaiser","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2020.07.034_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.canlet.2020.07.034_bib16","first-page":"4859","article-title":"Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells","volume":"49","author":"Judde","year":"1989","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib17","first-page":"2157","article-title":"Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice","volume":"5","author":"Tan","year":"1999","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.canlet.2018.06.016","article-title":"Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer","volume":"432","author":"Kawaguchi","year":"2018","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.07.034_bib19","first-page":"8","article-title":"Efficacy of recombinant methioninase (rMETase) on recalcitrant cancer patient-derived orthotopic xenograft (PDOX) mouse models: a review","author":"Kawaguchi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2020.07.034_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.canlet.2020.07.034_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrc821","article-title":"Targeting death and decoy receptors of the tumour-necrosis factor superfamily","volume":"2","author":"Ashkenazi","year":"2002","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2020.07.034_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.1364","article-title":"Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas","volume":"200","author":"Koornstra","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2020.07.034_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2407-7-108","article-title":"Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression","volume":"7","author":"Vigneswaran","year":"2007","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2020.07.034_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lungcan.2007.12.011","article-title":"Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer","volume":"61","author":"Greco","year":"2008","journal-title":"Lung Canc."},{"key":"10.1016\/j.canlet.2020.07.034_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.bjc.6605507","article-title":"Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer","volume":"102","author":"Trarbach","year":"2010","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2020.07.034_bib26","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1158\/0008-5472.CAN-04-0592","article-title":"Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress","volume":"64","author":"Kokkinakis","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib27","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1158\/1535-7163.MCT-05-0141","article-title":"Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma","volume":"4","author":"Kokkinakis","year":"2005","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2020.07.034_bib28","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-14-2792","article-title":"Methionine deprivation induces a targetable vulnerability in triple-negative breast cancer cells by enhancing TRAIL receptor-2 expression","volume":"21","author":"Strekalova","year":"2015","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-4804(03)00234-8","article-title":"A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics","volume":"113","author":"Katz","year":"2003","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib30","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1073\/pnas.89.12.5645","article-title":"A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens","volume":"89","author":"Fu","year":"1992","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.canlet.2020.07.034_bib31","first-page":"3070","article-title":"A novel \u201cpatient-like\u201d treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice","volume":"53","author":"Furukawa","year":"1993","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000495574","article-title":"Combining tumor-selective bacterial therapy with Salmonella typhimurium A1-R and cancer metabolism targeting with oral recombinant methioninase regressed an ewing's sarcoma in a patient-derived orthotopic xenograft model","volume":"63","author":"Miyake","year":"2018","journal-title":"Chemotherapy"},{"key":"10.1016\/j.canlet.2020.07.034_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/annonc\/mdn015","article-title":"A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes","volume":"19","author":"Yada","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2020.07.034_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/prep.1996.0700","article-title":"Overexpression and large-scale production of recombinantl-methionine-\u03b1-deamino-\u03b3-mercaptomethane-lyase for novel anticancer therapy","volume":"9","author":"Tan","year":"1997","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.canlet.2020.07.034_bib53","unstructured":"Sun X, Tan Y, Yang Z, Li S, Hoffman RM. A rapid HPLC method for the measurement of ultra-low plasma methionine concentrations applicable to methionine depletion therapy. Anticancer Res. (2005) 25(1A):59-62."},{"key":"10.1016\/j.canlet.2020.07.034_bib35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/15384101.2017.1423223","article-title":"Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse model","volume":"17","author":"Miyake","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2020.07.034_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1245\/s10434-013-3390-y","article-title":"Immunological impact of neoadjuvant chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma","volume":"21","author":"Homma","year":"2014","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2020.07.034_bib37","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/carcin\/bgs236","article-title":"The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells","volume":"33","author":"Tseng","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2020.07.034_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4939-8796-2_20","article-title":"Methionine-Positron-Emission Tomography (MET-PET)","volume":"1866","author":"Hoffman","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.canlet.2020.07.034_bib11","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.18632\/oncotarget.2369","article-title":"Selective methioninase-induced trap of cancer cells in S\/G2 phase visualized by FUCCI imaging confers chemosensitivity","volume":"5","author":"Yano","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.07.034_bib39","first-page":"2583","article-title":"Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase","volume":"58","author":"Yoshioka","year":"1998","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib55","first-page":"4371","article-title":"Methionine-depletion modulates the efficacy of 5-fluorouracil in human gastric cancer in nude mice","volume":"17","author":"Hoshiya","year":"1997","journal-title":"Anticancer Res"},{"issue":"7769","key":"10.1016\/j.canlet.2020.07.034_bib40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41586-019-1437-3","article-title":"Dietary methionine influences therapy in mouse cancer models and alters human metabolism","volume":"572","author":"Gao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.07.034_bib56","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1158\/0008-5472.CAN-04-1822","article-title":"PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer research"},{"key":"10.1016\/j.canlet.2020.07.034_bib41","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","article-title":"TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL","volume":"16","author":"Walczak","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2020.07.034_bib42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejca.2011.12.008","article-title":"First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I\/II open-label and double-blind study","volume":"48","author":"Demetri","year":"2012","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.canlet.2020.07.034_bib43","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/cam4.137","article-title":"Phase 2, multicenter, open-label study of tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy-naive patients with unresectable or metastatic pancreatic cancer","volume":"2","author":"Forero-Torres","year":"2013","journal-title":"Canc. Med."},{"key":"10.1016\/j.canlet.2020.07.034_bib44","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1158\/1078-0432.CCR-14-2780","article-title":"TBCRC 019: a phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple-negative breast cancer","volume":"21","author":"Forero-Torres","year":"2015","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib45","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1158\/1078-0432.CCR-07-4362","article-title":"Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels","volume":"14","author":"Lu","year":"2008","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib59","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1158\/1541-7786.MCR-08-0012","article-title":"Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand","volume":"6","author":"Yasuda","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.canlet.2020.07.034_bib58","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3892\/or.2013.2713","article-title":"Ibuprofen enhances TRAIL-induced apoptosis through DR5 upregulation","volume":"30","author":"Todo","year":"2013","journal-title":"Oncology reports"},{"key":"10.1016\/j.canlet.2020.07.034_bib47","first-page":"3857","article-title":"Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients","volume":"17","author":"Tan","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2020.07.034_bib48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer cell"},{"key":"10.1016\/j.canlet.2020.07.034_bib49","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2020.07.034_bib50","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1101\/gad.1475506","article-title":"Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression","volume":"20","author":"Ijichi","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2020.07.034_bib51","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.canlet.2020.07.034_bib52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2010.10.021","article-title":"Melanoma-associated antigen genes - an update","volume":"302","author":"Sang","year":"2011","journal-title":"Canc. Lett."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520303906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520303906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:51:46Z","timestamp":1759593106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520303906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":57,"alternative-id":["S0304383520303906"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.07.034","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}